Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Tarsus Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
LENSAR Inc. August 4, 202687.5%
-
RxSight Inc. June 16, 2026100.0%
-
Tarsus Pharmaceuticals Inc. June 13, 202484.3%
-
RxSight Inc. June 1, 202399.0%
-
LENSAR Inc. May 25, 202384.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Tarsus Pharmaceuticals Inc. | Option exercise | +201 | — | — |
| Sep 15, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −11,675 | $78.33 | $914,503 |
| Sep 15, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −759 | $79.00 | $59,961 |
| Sep 15, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −66 | $80.01 | $5,281 |
| Jun 17, 2026 | RxSight Inc. | Grant or award | +37,037 | — | — |
| Jun 15, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −10,572 | $61.97 | $655,147 |
| Jun 15, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −1,928 | $62.94 | $121,348 |
| Jun 12, 2026 | Tarsus Pharmaceuticals Inc. | Option exercise | +2,954 | — | — |
| Jun 3, 2026 | LENSAR Inc. | Grant or award | +17,421 | — | — |
| Mar 16, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −3,629 | $68.09 | $247,099 |
| Mar 16, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −8,378 | $69.03 | $578,333 |
| Mar 16, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −493 | $69.75 | $34,387 |
| Dec 15, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −5,046 | $80.80 | $407,717 |
| Dec 15, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −6,306 | $81.75 | $515,516 |
| Dec 15, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −1,148 | $82.39 | $94,584 |
Questions about William J. Link Ph.D.
What boards is William J. Link Ph.D. on?
William J. Link Ph.D. sits on the boards of LENSAR Inc., RxSight Inc. and Tarsus Pharmaceuticals Inc.
How long has William J. Link Ph.D. served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.